|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Iodoform | CAS 75-47-8 | ||
| CHI3 | RTECS PB7000000 | ||
|
Synonyms & Trade Names Triiodomethane |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.6 ppm (10 mg/m3) | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 16.10 mg/m3 | ||
|
Physical Description Yellow to greenish-yellow powder or crystalline solid with a pungent, disagreeable odor. [antiseptic for external use] |
|||
|
MW: 393.7 |
BP: 410°F (Decomposes) |
MLT: 246°F |
Sol: 0.01% |
|
VP: ? |
IP: ? |
|
Sp.Gr: 4.01 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers, lithium, metallic salts (e.g., mercuric oxide, silver nitrate), strong bases, calomel, tannin |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; lassitude (weakness, exhaustion), dizziness, nausea, incoordination, central nervous system depression; dyspnea (breathing difficulty); liver, kidney, heart damage; visual disturbance | |
|
Target Organs
Eyes, skin, respiratory system, liver, kidneys, heart |
|
| See also: INTRODUCTION |